NASDAQ · Biotechnology
Aurinia Pharmaceuticals Inc (AUPH)
$14.70
-1.28%
32
In band
Moving averages
SMA 200$15.71-6.43%
Company profile
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada.
SectorHealthcare
IndustryBiotechnology
Market cap$2.17B
P/E ratio7.11
EPS$2.28
Beta1.342
Dividend yield0.00%
52-week high$19.25
52-week low$13.52
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 34
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
SRPT
Sarepta Therapeutics Inc
RSI 29
ATAI
ATAI Life Sciences N.V.
RSI 62
NVAX
Novavax Inc
RSI 33
NTLA
Intellia Therapeutics Inc
RSI 37
RSI alerts for AUPH
An email when AUPH closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 3:10 AM EST